Regenerative Medicine Market, Latest Treatment Methodology and Research Report 2022-2030

Page 1

The global Regenerative Medicine Market is expected to reach USD 172.15 billion by 2030 from USD 13.96 billion in 2020, at a CAGR of 28.9%. Regenerative Medicine are used to regenerate, repair, replace or restore tissues and organs damaged by diseases or due to natural ageing. These medicines help in the restoration of normal cell functions and are widely used to treat various degenerative disorders such as cardiovascular disorders, orthopedic disorders and others. Stem cell plays an important role in regenerative medicine as they are capable of proliferating and differentiating into all cell types in an organism, including extra-embryonic tissues. Market Segmentations and Scope of the Study: The global regenerative medicine market is segmented based on product type, material, application, and geography. Based on product type, the market is classified into cell therapy, gene therapy, tissue engineering, and small molecule & biologic. Depending on material, it is categorized into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. Synthetic material is further divided into biodegradable synthetic polymer, scaffold, artificial vascular graft material, and hydrogel material. Biologically derived material is further bifurcated into collagen and xenogenic material. Genetically engineered material is further segmented into deoxyribonucleic acid, transfection vector, genetically manipulated cell, three-dimensional polymer technology, transgenic, fibroblast, neural stem cell, and gene-activated matrices. Pharmaceutical is further divided into small molecule and biologic. By application, it is categorized into cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. Geographically, it is analyzed across four regions, i.e., North America, Europe, Asia-Pacific, and RoW. Based on material, the market is divided into synthetic material, biologically derived material, genetically engineered material, and pharmaceutical. The biologically derived material was the dominant segment in 2019, and is estimated to maintain this trend during the analysis period. The demand for genetically engineered material has increased due to their unique properties such as promotion of cellular interactions, rise in proliferation, and differentiation of cells that facilitate selfassembly into directionally organized structures, and control the manipulation of cellular behavior. Regenerative medicine is applicable in cardiovascular, oncology, dermatology, musculoskeletal, wound healing, ophthalmology, neurology, and others. The musculoskeletal application segment accounted for the largest share in 2019, whereas cardiovascular is expected to be the fastestgrowing segment, registering a CAGR of 28.5% during the forecast period. Request for sample report: https://www.nextmsc.com/regenerative-medicine-market/requestsample Geographical Analysis:


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.
Regenerative Medicine Market, Latest Treatment Methodology and Research Report 2022-2030 by sheshk234 - Issuu